◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
BMY
BMY
(BMY)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
Business Wire
·
vor 18 Std.
Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026
Motley Fool
·
vor 18 Std.
Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors
Simply Wall St.
·
vor 22 Std.
Bristol Myers Squibb (BMY) Stock Looks Reasonable On Earnings Yet Strong Returns Test Value
Insider Monkey
·
vor 1 Tagen
Johnson & Johnson (JNJ) Taps Sail Biomedicines in Bid for CAR-T Edge Over Bristol Myers Squibb
Investor's Business Daily
·
vor 1 Tagen
Cytokinetics Boasts A First-Ever In Heart Disease — And Shares Drop
Insider Monkey
·
vor 1 Tagen
Can Atrium Therapeutics (RNA)’s $15 Million Milestone From Bristol-Myers Squibb (BMY) Validate its RNA Platform?
Frag BlackSpecter AI über BMY
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist BMY kaufenswert?
BMY Earnings Analyse
BMY Bewertung
AI Chat öffnen →